Background: This study presents a young man with hereditary spherocytosis (HS) who underwent intensive chemotherapy for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and achieved complete remission. This case challenges the idea of HS as a barrier to standard DLBCL treatment. Discussion: By meticulously monitoring blood counts and providing timely transfusions, the team successfully mitigated potential complications associated with chemotherapy-induced stress on red blood cells. Conclusions: This experience underscores the importance of a multidisciplinary approach and tailored treatment plans for patients with co-existing conditions, suggesting that HS should not automatically disqualify them from potentially curative therapies for aggressive lymphomas.
Feasibility of Intensive Chemotherapy in Hereditary Spherocytosis / Valentina, C., Cristina, G., Manuel, C., Simona, D., Luca, N., Benedetta, S., Alessandro Maria, V., Benedetta, P.. - In: HEMATOLOGY REPORTS. - ISSN 2038-8330. - ELETTRONICO. - 17:(2025), pp. 11.1-11.6. [10.3390/hematolrep17020011]
Feasibility of Intensive Chemotherapy in Hereditary Spherocytosis
Cristina, Giubbilei;Manuel, Ciceri;Simona, D'Angelo;Benedetta, Sordi;Alessandro Maria, Vannucchi;Benedetta, Puccini
2025
Abstract
Background: This study presents a young man with hereditary spherocytosis (HS) who underwent intensive chemotherapy for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and achieved complete remission. This case challenges the idea of HS as a barrier to standard DLBCL treatment. Discussion: By meticulously monitoring blood counts and providing timely transfusions, the team successfully mitigated potential complications associated with chemotherapy-induced stress on red blood cells. Conclusions: This experience underscores the importance of a multidisciplinary approach and tailored treatment plans for patients with co-existing conditions, suggesting that HS should not automatically disqualify them from potentially curative therapies for aggressive lymphomas.| File | Dimensione | Formato | |
|---|---|---|---|
|
hematolrep-17-00011.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
559.02 kB
Formato
Adobe PDF
|
559.02 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



